approval
saveOMVOH (MIRIKIZUMAB-MRKZ) — FDA approval
community read0 votes
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 6
- approvallebrikizumab: EBGLYSS (LEBRIKIZUMAB-LBKZ) — FDA approvalOct 28, 2025
- approvalZEPBOUND: ZEPBOUND (TIRZEPATIDE) — FDA approvalSep 25, 2025
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalNov 20, 2025
- approvalZEPBOUND: MOUNJARO (TIRZEPATIDE) — FDA approvalSep 25, 2025
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalNov 20, 2025
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalNov 20, 2025
comments(0)
5-min edit window · permanent after that